109 related articles for article (PubMed ID: 38809117)
1. Mito-Specific Nutri-Hijacker Synergizing Mitochondrial Metabolism and Glycolysis Intervention for Enhanced Antitumor Bioenergetic Therapy.
Yang J; Chu M; Zhang Y; Qian J; Liu J; Wang M; Qiang Z; Ren J
ACS Appl Mater Interfaces; 2024 Jun; 16(23):29902-29916. PubMed ID: 38809117
[TBL] [Abstract][Full Text] [Related]
2. Synchronous Interventions of Glucose and Mitochondrial Metabolisms for Antitumor Bioenergetic Therapy.
Li M; Luo X; Lei S; Liu Y; Guo H; Zhang Y; Pan Y; Chen K; Lin J; Huang P
Adv Mater; 2023 Jul; 35(29):e2301099. PubMed ID: 37086266
[TBL] [Abstract][Full Text] [Related]
3. Antiproliferative effects of mitochondria-targeted cationic antioxidants and analogs: Role of mitochondrial bioenergetics and energy-sensing mechanism.
Cheng G; Zielonka J; McAllister D; Hardy M; Ouari O; Joseph J; Dwinell MB; Kalyanaraman B
Cancer Lett; 2015 Aug; 365(1):96-106. PubMed ID: 26004344
[TBL] [Abstract][Full Text] [Related]
4. Dual inhibition of oxidative phosphorylation and glycolysis to enhance cancer therapy.
Sheng X; Wang MM; Zhang GD; Su Y; Fang HB; Yu ZH; Su Z
Bioorg Chem; 2024 Jun; 147():107325. PubMed ID: 38583247
[TBL] [Abstract][Full Text] [Related]
5. Mito-DCA: a mitochondria targeted molecular scaffold for efficacious delivery of metabolic modulator dichloroacetate.
Pathak RK; Marrache S; Harn DA; Dhar S
ACS Chem Biol; 2014 May; 9(5):1178-87. PubMed ID: 24617941
[TBL] [Abstract][Full Text] [Related]
6. Boosting Energy Deprivation by Synchronous Interventions of Glycolysis and Oxidative Phosphorylation for Bioenergetic Therapy Synergetic with Chemodynamic/Photothermal Therapy.
Wei X; Han R; Gao Y; Song P; Guo Z; Hou Y; Yu J; Tang K
Adv Sci (Weinh); 2024 Jun; 11(23):e2401738. PubMed ID: 38489668
[TBL] [Abstract][Full Text] [Related]
7. Mitochondria and cancer chemoresistance.
Guerra F; Arbini AA; Moro L
Biochim Biophys Acta Bioenerg; 2017 Aug; 1858(8):686-699. PubMed ID: 28161329
[TBL] [Abstract][Full Text] [Related]
8. Ginsenoside Rh2 shifts tumor metabolism from aerobic glycolysis to oxidative phosphorylation through regulating the HIF1-α/PDK4 axis in non-small cell lung cancer.
Liu X; Li J; Huang Q; Jin M; Huang G
Mol Med; 2024 Apr; 30(1):56. PubMed ID: 38671369
[TBL] [Abstract][Full Text] [Related]
9. The Warburg effect in tumor progression: mitochondrial oxidative metabolism as an anti-metastasis mechanism.
Lu J; Tan M; Cai Q
Cancer Lett; 2015 Jan; 356(2 Pt A):156-64. PubMed ID: 24732809
[TBL] [Abstract][Full Text] [Related]
10. Targeting tumor glycolysis by a mitotropic agent.
Ganapathy-Kanniappan S
Expert Opin Ther Targets; 2016; 20(1):1-5. PubMed ID: 26420565
[TBL] [Abstract][Full Text] [Related]
11. Mitochondria-targeted vitamin E analogs inhibit breast cancer cell energy metabolism and promote cell death.
Cheng G; Zielonka J; McAllister DM; Mackinnon AC; Joseph J; Dwinell MB; Kalyanaraman B
BMC Cancer; 2013 Jun; 13():285. PubMed ID: 23764021
[TBL] [Abstract][Full Text] [Related]
12. The multikinase inhibitor Sorafenib enhances glycolysis and synergizes with glycolysis blockade for cancer cell killing.
Tesori V; Piscaglia AC; Samengo D; Barba M; Bernardini C; Scatena R; Pontoglio A; Castellini L; Spelbrink JN; Maulucci G; Puglisi MA; Pani G; Gasbarrini A
Sci Rep; 2015 Mar; 5():9149. PubMed ID: 25779766
[TBL] [Abstract][Full Text] [Related]
13. Relationship Between Metabolic Reprogramming and Mitochondrial Activity in Cancer Cells. Understanding The Anticancer Effect of Metformin and Its Clinical Implications.
Cazzaniga M; Bonanni B
Anticancer Res; 2015 Nov; 35(11):5789-96. PubMed ID: 26503999
[TBL] [Abstract][Full Text] [Related]
14. Bezielle selectively targets mitochondria of cancer cells to inhibit glycolysis and OXPHOS.
Chen V; Staub RE; Fong S; Tagliaferri M; Cohen I; Shtivelman E
PLoS One; 2012; 7(2):e30300. PubMed ID: 22319564
[TBL] [Abstract][Full Text] [Related]
15. The dichotomous role of the glycolytic metabolism pathway in cancer metastasis: Interplay with the complex tumor microenvironment and novel therapeutic strategies.
El Hassouni B; Granchi C; Vallés-Martí A; Supadmanaba IGP; Bononi G; Tuccinardi T; Funel N; Jimenez CR; Peters GJ; Giovannetti E; Minutolo F
Semin Cancer Biol; 2020 Feb; 60():238-248. PubMed ID: 31445217
[TBL] [Abstract][Full Text] [Related]
16. Mitochondria-targeted drugs synergize with 2-deoxyglucose to trigger breast cancer cell death.
Cheng G; Zielonka J; Dranka BP; McAllister D; Mackinnon AC; Joseph J; Kalyanaraman B
Cancer Res; 2012 May; 72(10):2634-44. PubMed ID: 22431711
[TBL] [Abstract][Full Text] [Related]
17. Targeting Energy Metabolism by a Platinum(IV) Prodrug as an Alternative Pathway for Cancer Suppression.
Jin S; Guo Y; Song D; Zhu Z; Zhang Z; Sun Y; Yang T; Guo Z; Wang X
Inorg Chem; 2019 May; 58(9):6507-6516. PubMed ID: 31013065
[TBL] [Abstract][Full Text] [Related]
18. Metabolic reprogramming and AMPKα1 pathway activation by caulerpin in colorectal cancer cells.
Yu H; Zhang H; Dong M; Wu Z; Shen Z; Xie Y; Kong Z; Dai X; Xu B
Int J Oncol; 2017 Jan; 50(1):161-172. PubMed ID: 27922662
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of mitochondrial function and metabolic reprogramming during tumor progression in a cell model of skin carcinogenesis.
Vallejo CG; Cruz-Bermúdez A; Clemente P; Hernández-Sierra R; Garesse R; Quintanilla M
Biochimie; 2013 Jun; 95(6):1171-6. PubMed ID: 23353111
[TBL] [Abstract][Full Text] [Related]
20. NIR-II imaging-guided precise photodynamic therapy for augmenting tumor-starvation therapy by glucose metabolism reprogramming interference.
Wu X; Fan Y; Wang K; Miao Y; Chang Y; Ming J; Wang X; Lu S; Liu R; Zhang F; Zhang Y; Qin H; Shi J
Sci Bull (Beijing); 2024 May; 69(9):1263-1274. PubMed ID: 38418300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
